Norway Savings Bank’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,490
Closed -$224K 251
2018
Q4
$224K Buy
3,490
+270
+8% +$19.9K 0.22% 90
2018
Q3
$288K Sell
3,220
-105
-3% -$9.28K 0.25% 81
2018
Q2
$264K Buy
3,325
+360
+12% +$29.9K 0.24% 83
2018
Q1
$264K Sell
2,965
-1,160
-28% -$111K 0.25% 82
2017
Q4
$430K Buy
4,125
+255
+7% +$28.8K 0.4% 62
2017
Q3
$565K Sell
3,870
-220
-5% -$30K 0.54% 53
2017
Q2
$531K Sell
4,090
-100
-2% -$12.3K 0.52% 55
2017
Q1
$521K Sell
4,190
-175
-4% -$20.9K 0.54% 56
2016
Q4
$505K Buy
+4,365
New +$486K 0.47% 63

Other funds holding CELG

Norway Savings Bank's CELG Position: Q1 2019 in Review

Norway Savings Bank sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 3,490 shares — an estimated $224K sold.

Norway Savings Bank first reported a position in CELG in Q4 2016 and held it in 9 quarters. The position peaked at $565K in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Norway Savings Bank reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Norway Savings Bank sold 3,490 Celgene Corp shares in Q1 2019, an estimated $224K.
  • Norway Savings Bank first reported a position in Celgene Corp in Q4 2016 and held it in 9 quarters.
  • Norway Savings Bank's Celgene Corp position peaked at $565K in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Norway Savings Bank's 13F filing for Q1 2019, filed 12 Apr 2019.